These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 29383936)

  • 1. Novel RAS Inhibitors Poricoic Acid ZG and Poricoic Acid ZH Attenuate Renal Fibrosis via a Wnt/β-Catenin Pathway and Targeted Phosphorylation of smad3 Signaling.
    Wang M; Chen DQ; Chen L; Liu D; Zhao H; Zhang ZH; Vaziri ND; Guo Y; Zhao YY; Cao G
    J Agric Food Chem; 2018 Feb; 66(8):1828-1842. PubMed ID: 29383936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis.
    Wang M; Chen DQ; Chen L; Cao G; Zhao H; Liu D; Vaziri ND; Guo Y; Zhao YY
    Br J Pharmacol; 2018 Jul; 175(13):2689-2708. PubMed ID: 29679507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.
    Wang M; Chen DQ; Wang MC; Chen H; Chen L; Liu D; Zhao H; Zhao YY
    Phytomedicine; 2017 Dec; 36():243-253. PubMed ID: 29157821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
    Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
    Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel poricoic acids attenuate renal fibrosis through regulating redox signalling and aryl hydrocarbon receptor activation.
    Wang M; Hu HH; Chen YY; Chen L; Wu XQ; Zhao YY
    Phytomedicine; 2020 Dec; 79():153323. PubMed ID: 32920287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WNT/β-catenin signal inhibitor IC-2-derived small-molecule compounds suppress TGF-β1-induced fibrogenic response of renal epithelial cells by inhibiting SMAD2/3 signalling.
    Hoi S; Tsuchiya H; Itaba N; Suzuki K; Oka H; Morimoto M; Takata T; Isomoto H; Shiota G
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):940-946. PubMed ID: 32012313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined melatonin and poricoic acid A inhibits renal fibrosis through modulating the interaction of Smad3 and β-catenin pathway in AKI-to-CKD continuum.
    Chen DQ; Cao G; Zhao H; Chen L; Yang T; Wang M; Vaziri ND; Guo Y; Zhao YY
    Ther Adv Chronic Dis; 2019; 10():2040622319869116. PubMed ID: 31452866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poricoic acid A activates AMPK to attenuate fibroblast activation and abnormal extracellular matrix remodelling in renal fibrosis.
    Chen DQ; Wang YN; Vaziri ND; Chen L; Hu HH; Zhao YY
    Phytomedicine; 2020 Jul; 72():153232. PubMed ID: 32460034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway.
    Huang XZ; Wen D; Zhang M; Xie Q; Ma L; Guan Y; Ren Y; Chen J; Hao CM
    J Cell Biochem; 2014 May; 115(5):996-1005. PubMed ID: 24356887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
    Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
    Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential therapeutic efficacy of pachymic acid in chronic kidney disease induced in rats: role of Wnt/β-catenin/renin-angiotensin axis.
    Younis NN; Mohamed HE; Shaheen MA; Abdelghafour AM; Hammad SK
    J Pharm Pharmacol; 2022 Jan; 74(1):112-123. PubMed ID: 34549301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel role of LRP5 in tubulointerstitial fibrosis through activating TGF-β/Smad signaling.
    He X; Cheng R; Huang C; Takahashi Y; Yang Y; Benyajati S; Chen Y; Zhang XA; Ma JX
    Signal Transduct Target Ther; 2020 Apr; 5(1):45. PubMed ID: 32345960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poricoic acid A suppresses renal fibroblast activation and interstitial fibrosis in UUO rats via upregulating Sirt3 and promoting β-catenin K49 deacetylation.
    Chen DQ; Chen L; Guo Y; Wu XQ; Zhao TT; Zhao HL; Zhang HJ; Yan MH; Zhang GQ; Li P
    Acta Pharmacol Sin; 2023 May; 44(5):1038-1050. PubMed ID: 36470978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of RAS/Wnt/β-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy.
    Chen L; Chen DQ; Wang M; Liu D; Chen H; Dou F; Vaziri ND; Zhao YY
    Chem Biol Interact; 2017 Aug; 273():56-72. PubMed ID: 28578904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ShenKang injection suppresses kidney fibrosis and oxidative stress via transforming growth factor-β/Smad3 signalling pathway in vivo and in vitro.
    Wu X; Guan Y; Yan J; Liu M; Yin Y; Duan J; Wei G; Hu T; Weng Y; Xi M; Wen A
    J Pharm Pharmacol; 2015 Aug; 67(8):1054-65. PubMed ID: 25864844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/β-catenin signaling pathway contributes to isoflurane postconditioning against cerebral ischemia-reperfusion injury and is possibly related to the transforming growth factorβ1/Smad3 signaling pathway.
    Zhang G; Ge M; Han Z; Wang S; Yin J; Peng L; Xu F; Zhang Q; Dai Z; Xie L; Li Y; Si J; Ma K
    Biomed Pharmacother; 2019 Feb; 110():420-430. PubMed ID: 30530044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulation of Hippo-TAZ pathway during renal injury confers a fibrotic maladaptive phenotype.
    Anorga S; Overstreet JM; Falke LL; Tang J; Goldschmeding RG; Higgins PJ; Samarakoon R
    FASEB J; 2018 May; 32(5):2644-2657. PubMed ID: 29298862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Wnt/β-catenin signalling is required for TGF-β/Smad2/3 signalling during myofibroblast proliferation.
    Xu L; Cui WH; Zhou WC; Li DL; Li LC; Zhao P; Mo XT; Zhang Z; Gao J
    J Cell Mol Med; 2017 Aug; 21(8):1545-1554. PubMed ID: 28244647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GQ5 Hinders Renal Fibrosis in Obstructive Nephropathy by Selectively Inhibiting TGF-β-Induced Smad3 Phosphorylation.
    Ai J; Nie J; He J; Guo Q; Li M; Lei Y; Liu Y; Zhou Z; Zhu F; Liang M; Cheng Y; Hou FF
    J Am Soc Nephrol; 2015 Aug; 26(8):1827-38. PubMed ID: 25392233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zishen Qingre Tongluo Formula Improves Renal Fatty Acid Oxidation and Alleviated Fibrosis via the Regulation of the TGF-
    Liu P; Wang C; Wang Y; Zhang H; Liu B; Qiu X
    Biomed Res Int; 2021; 2021():2793823. PubMed ID: 34938805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.